First Allied Advisory Services’s Regeneron Pharmaceuticals REGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q3
$1.08M Sell
1,939
-1,261
-39% -$765K 0.04% 451
2020
Q2
$2M Buy
3,200
+1,259
+65% +$715K 0.07% 271
2020
Q1
$948K Sell
1,941
-66
-3% -$27.2K 0.04% 402
2019
Q4
$758K Sell
2,007
-1,082
-35% -$364K 0.03% 573
2019
Q3
$853K Sell
3,089
-555
-15% -$164K 0.03% 509
2019
Q2
$1.14M Sell
3,644
-5
-0.1% -$1.67K 0.04% 427
2019
Q1
$1.49M Buy
3,649
+74
+2% +$30.5K 0.05% 357
2018
Q4
$1.33M Buy
3,575
+501
+16% +$183K 0.05% 350
2018
Q3
$1.24M Buy
3,074
+424
+16% +$161K 0.04% 411
2018
Q2
$913K Buy
2,650
+415
+19% +$130K 0.03% 482
2018
Q1
$767K Buy
2,235
+27
+1% +$9.39K 0.03% 528
2017
Q4
$835K Buy
2,208
+354
+19% +$143K 0.03% 497
2017
Q3
$827K Buy
1,854
+226
+14% +$108K 0.04% 467
2017
Q2
$797K Sell
1,628
-40
-2% -$17.5K 0.04% 483
2017
Q1
$646K Buy
1,668
+53
+3% +$19.6K 0.03% 503
2016
Q4
$593K Buy
1,615
+119
+8% +$45.3K 0.03% 530
2016
Q3
$601K Buy
1,496
+90
+6% +$36.1K 0.03% 506
2016
Q2
$487K Buy
1,406
+60
+4% +$23.1K 0.03% 560
2016
Q1
$485K Sell
1,346
-815
-38% -$336K 0.03% 548
2015
Q4
$1.17M Buy
2,161
+89
+4% +$48.2K 0.06% 328
2015
Q3
$962K Sell
2,072
-71
-3% -$38.1K 0.05% 357
2015
Q2
$1.1M Sell
2,143
-158
-7% -$77.1K 0.05% 373
2015
Q1
$1.03M Sell
2,301
-180
-7% -$76.3K 0.07% 343
2014
Q4
$1.01M Sell
2,481
-1,236
-33% -$486K 0.07% 317
2014
Q3
$1.34M Buy
3,717
+720
+24% +$241K 0.11% 227
2014
Q2
$846K Sell
2,997
-257
-8% -$76.2K 0.06% 368
2014
Q1
$977K Buy
3,254
+2,304
+243% +$710K 0.07% 305
2013
Q4
$261K Sell
950
-1,838
-66% -$529K 0.02% 726
2013
Q3
$871K Buy
+2,788
New +$733K 0.05% 344

Other funds holding REGN